ANI Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
ANI Pharmaceuticals has a total shareholder equity of $480.6M and total debt of $285.2M, which brings its debt-to-equity ratio to 59.4%. Its total assets and total liabilities are $920.8M and $440.1M respectively. ANI Pharmaceuticals's EBIT is $48.2M making its interest coverage ratio 2.3. It has cash and short-term investments of $247.1M.
Key information
59.4%
Debt to equity ratio
US$285.24m
Debt
| Interest coverage ratio | 2.3x |
| Cash | US$247.05m |
| Equity | US$480.61m |
| Total liabilities | US$440.14m |
| Total assets | US$920.75m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BSFA's short term assets ($555.5M) exceed its short term liabilities ($140.0M).
Long Term Liabilities: BSFA's short term assets ($555.5M) exceed its long term liabilities ($300.2M).
Debt to Equity History and Analysis
Debt Level: BSFA's net debt to equity ratio (7.9%) is considered satisfactory.
Reducing Debt: BSFA's debt to equity ratio has reduced from 92.5% to 59.4% over the past 5 years.
Debt Coverage: BSFA's debt is well covered by operating cash flow (39.5%).
Interest Coverage: BSFA's interest payments on its debt are not well covered by EBIT (2.3x coverage).